Robin Garner
Stock Analyst at Craig-Hallum
(0.53)
# 3,089
Out of 4,667 analysts
4
Total ratings
25%
Success rate
-8.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robin Garner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings | Initiates: Buy | $4.5 | $3.06 | +47.06% | 2 | Aug 28, 2023 | |
| CUE Cue Biopharma | Maintains: Buy | $28 → $26 | $1.09 | +2,285.32% | 1 | Mar 18, 2022 | |
| FENC Fennec Pharmaceuticals | Initiates: Buy | $17 | $4.64 | +266.38% | 1 | Apr 21, 2021 |
Xeris Biopharma Holdings
Aug 28, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.06
Upside: +47.06%
Cue Biopharma
Mar 18, 2022
Maintains: Buy
Price Target: $28 → $26
Current: $1.09
Upside: +2,285.32%
Fennec Pharmaceuticals
Apr 21, 2021
Initiates: Buy
Price Target: $17
Current: $4.64
Upside: +266.38%